Literature DB >> 7804691

Donor mononuclear cell infusions as therapy for B-cell lymphoproliferative disorder following allogeneic bone marrow transplant.

D L Porter1, G J Orloff, J H Antin.   

Abstract

Entities:  

Mesh：

Year:  1994        PMID： 7804691

Source DB:  PubMed          Journal:  Transplant Sci        ISSN： 1063-2964


× No keyword cloud information.
  6 in total

1.  Generation of tumor antigen-specific T cell lines from pediatric patients with acute lymphoblastic leukemia--implications for immunotherapy.

Authors:  Gerrit Weber; Ignazio Caruana; Rayne H Rouce; A John Barrett; Ulrike Gerdemann; Ann M Leen; Karen R Rabin; Catherine M Bollard
Journal:  Clin Cancer Res       Date:  2013-07-09       Impact factor: 12.531

Review 2.  Adoptive immunotherapy for Epstein-Barr virus-associated lymphoproliferative disorders complicating marrow allografts.

Authors:  R J O'Reilly; T N Small; E Papadopoulos; K Lucas; J Lacerda; L Koulova
Journal:  Springer Semin Immunopathol       Date:  1998

Review 3.  NCI First International Workshop on The Biology, Prevention and Treatment of Relapse after Allogeneic Hematopoietic Cell Transplantation: report from the committee on prevention of relapse following allogeneic cell transplantation for hematologic malignancies.

Authors:  Edwin P Alyea; Daniel J DeAngelo; Jeffrey Moldrem; John M Pagel; Donna Przepiorka; Michel Sadelin; James W Young; Sergio Giralt; Michael Bishop; Stan Riddell
Journal:  Biol Blood Marrow Transplant       Date:  2010-05-24       Impact factor: 5.742

4.  CD40-activated human B cells: an alternative source of highly efficient antigen presenting cells to generate autologous antigen-specific T cells for adoptive immunotherapy.

Authors:  J L Schultze; S Michalak; M J Seamon; G Dranoff; K Jung; J Daley; J C Delgado; J G Gribben; L M Nadler
Journal:  J Clin Invest       Date:  1997-12-01       Impact factor: 14.808

Review 5.  Posttransplant chimeric antigen receptor therapy.

Authors:  Melody Smith; Johannes Zakrzewski; Scott James; Michel Sadelain
Journal:  Blood       Date:  2018-01-22       Impact factor: 22.113

6.  Cellular therapy following allogeneic stem-cell transplantation.

Authors:  Alison Rager; David L Porter
Journal:  Ther Adv Hematol       Date:  2011-12
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.